Institutional Ownership
Altamira Therapeutics Ltd Shs
CUSIP G0360L134StockQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
18.9%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 189.6K | SEC |
| 2 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 10.0% | 228.6K | SEC |
| 3 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 10.0% | 473.9K | SEC |
| 4 | May 6, 2025 | Thomas Meyer | 13D/A | 18.9% | — | SEC |
| 5 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 10.0% | 478.5K | SEC |
| 6 | Nov 14, 2024 | Armistice Capital, LLC | 13G | 10.0% | 408.1K | SEC |
| 7 | Mar 13, 2024 | Meyer Thomas | 13D/A | 1.2% | 22.3K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lri Investments, LLC | 1 | $0 |